Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-102.8%
operating margin TTM
-181.69%
revenue TTM
10.58 Million
revenue per share TTM
4.62$
valuation ratios | |
|---|---|
| pe ratio | -2,608.22 |
| peg ratio | -26.08 |
| price to book ratio | -4,604.90 |
| price to sales ratio | 0.50 |
| enterprise value multiple | -1.09 |
| price fair value | -4,604.90 |
profitability ratios | |
|---|---|
| gross profit margin | 60.31% |
| operating profit margin | -181.69% |
| pretax profit margin | -102.8% |
| net profit margin | -102.8% |
| return on assets | -45.82% |
| return on equity | 632.59% |
| return on capital employed | 349.59% |
liquidity ratio | |
|---|---|
| current ratio | 0.54 |
| quick ratio | 0.37 |
| cash ratio | 0.21 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 417.49 |
| operating cycle | 579.31 |
| days of payables outstanding | 898.89 |
| cash conversion cycle | -319.58 |
| receivables turnover | 2.26 |
| payables turnover | 0.41 |
| inventory turnover | 0.87 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | -0.08 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | -0.08 |
| interest coverage | -265.69 |
| cash flow to debt ratio | -26.32 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.00 |
| cash per share | 0.00 |
| operating cash flow per share | -0.00 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -26.32 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -1,041.00 |
Frequently Asked Questions
When was the last time RedHill Biopharma Ltd. (NASDAQ:RDHL) reported earnings?
RedHill Biopharma Ltd. (RDHL) published its most recent earnings results on 17-08-2023.
What is RedHill Biopharma Ltd.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. RedHill Biopharma Ltd. (NASDAQ:RDHL)'s trailing twelve months ROE is 632.59%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. RedHill Biopharma Ltd. (RDHL) currently has a ROA of -45.82%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did RDHL's net profit margin stand at?
RDHL reported a profit margin of -102.8% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is RDHL's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.54 in the most recent quarter. The quick ratio stood at 0.37, with a Debt/Eq ratio of -0.08.